NetraMark Holdings Inc. (CSE:AIAI)

Canada flag Canada · Delayed Price · Currency is CAD
0.9900
-0.0600 (-5.71%)
Feb 9, 2026, 10:29 AM EST
Market Cap96.40M +43.3%
Revenue (ttm)165.26K -80.4%
Net Income-5.80M
EPS-0.07
Shares Out91.81M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,001
Average Volume75,782
Open1.0300
Previous Close1.0500
Day's Range0.9900 - 1.0300
52-Week Range0.9300 - 1.8000
Beta1.59
RSI42.35
Earnings DateJan 15, 2026

About NetraMark Holdings

NetraMark Holdings Inc. provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies worldwide. It operates NetraAI platform, an advanced machine learning system purpose-built for analyzing complex clinical trial data to identify meaningful patient subpopulations. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc. was founded in 2016 and is headquartered in Toronto, Canada. [Read more]

Sector Healthcare
Founded 2016
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol AIAI
Full Company Profile

Financial Performance

In fiscal year 2025, NetraMark Holdings's revenue was 432,495, a decrease of -5.18% compared to the previous year's 456,127. Losses were -5.22 million, 56.7% more than in 2024.

Financial Statements